New gene test on the market

News RSS feed

Investment in promising method for treatment of chronical diabetes foot ulcers

(02.09.2010) The Danish company Reapplix has developed the product LeucoPatch ™ for treatment of severe chronic foot ulcers. The prod...
Read more

SEED Capital has invested in 11 new growth companies in first 2 quarters of 2010

(6.07.2010) In a time of crisis with far between the positive stories, and with banks and investors keeping a lid on spending, the venture...
Read more

Nangate on Red Herrings hot list

(28.5.2010) Nangate has been listed on Red Herring's list of the top 100 most innovative companies in Europe in 2010. Red Her...
Read more

How we work with business proposals

Out of more than 400 business proposals presented each year, DSI invests in up to 15 new companies. DSI evaluates all proposals in se...
Read more

New gene test on the market

(9.6.2006) The Medical Prognosis Institute in cooporation with Capio Diagnostik and Roche Diagnostics is launching a gene test that is capable of determining the correct doses of critical medicine. This opens the path to personalized medication. The product will be on the market in the beginning of June.

For more information about the Medical Prognosis Institute, see our portfolio description.